Resources

Showing 56 Results

Health Care Spending Guiding Principles

NPC established a set of principles to assess health care spending estimates and policies to ensure alignment with the goals of patient-centered care.

Patient-Centered Guiding Principles for Evaluating Health Care Spending

NPC established these principles to serve as a checklist to assess whether methods used for estimating health care spending are appropriate.

Patient-Centered Guiding Principles for Reforming Health Care to Address Rising Health Care Spending

NPC established these principles to assess health care spending policies to ensure alignment with the goals of patient-centered care.

Health Spending Post-Pandemic: Looking for High Value Beyond the Headlines

NPC Chief Science Officer Dr. Sharon Phares takes a closer look at CMS' national health expenditure report and what their predictions mean for our health care system.

Drug Price Regulation Trade-offs: Real or Imagined?

NPC hosted a panel at AcademyHealth’s National Health Policy Conference to explore the potential risks and unintended consequences of drug price regulation.

Scientist working with a pipette and test tubes

Continuing Innovation for Rare Conditions Under the Orphan Drug Act 

The Orphan Drug Act has served as a catalyst for the development of many innovative therapies to treat rare diseases. Without the appropriate incentives to develop therapies for rare or ultra-rare…

Innovating to Help Patients with Rare Diseases

One out of every 10 Americans live with a rare disease. Rare Disease Week serves as a reminder of their many needs and challenges and the work that researchers, clinicians, and our member companies…

What If Groundbreaking Medicines Never Existed?

New research from estimates what health gains might have been lost without the introduction of influential innovations for six serious diseases.

What Might Have Happened: The Impact of Interrupting Entry of Innovative Drugs on Disease Outcomes in the United States

A new NPC study shows how major drug innovations significantly improved patient health outcomes for six diseases with substantial mortality or morbidity.

The Certainty of Uncertainty in Health Technology Assessment 

A new Health Affairs Forefront article from Tufts CEVR examines the potential flaws in how health technology assessments identify and report on uncertainty.

NPC in RealClearPolicy: Price Setting Bill Is No Panacea for Patients

In a commentary for RealClearPolicy, NPC’s John M. O’Brien explains how the drug pricing deal in the Build Back Better Act could create harmful unintended consequences for patient health and the…

JMCP Drug Spending Mirrors Health Care Spending

Health Spending for Commercial Plans Is Predominantly Concentrated In Small Population of High-Intensity Consumers

NPC study finds spending on prescription drugs mirrors spending on other health care services, with a small subset of the sickest patients driving the majority of spending.

Drug Spending Mirrors Spending on Other Health Care Services

Spending on prescription drugs is not an anomaly but rather follows similar patterns as other health care services. Policy proposals that focus narrowly on constraining drug spending are disregarding…

At the Heart of It: How Innovation Drives Improved Patient Outcomes

In honor of World Heart Day, NPC looks at how innovative medical interventions have vastly improved cardiovascular disease outcomes.

A Healthier Country Means Lower Health Care Spending

The U.S. spends twice as much per person on health care compared to other wealthy countries. While higher U.S. health care prices play a role in this disparity, they are not the only cause. A new NPC…

It Is Not Just the Prices! The Role of Chronic Disease in Accounting for Higher Health Care Spending in the United States

A new NPC study shows that the higher prevalence of chronic disease in the U.S. is a significant contributing factor to high U.S. health care spending.

Filter by: